Literature DB >> 26077014

A knowledgebase resource for interleukin-17 family mediated signaling.

Jyoti Sharma1,2, Lavanya Balakrishnan3, Keshava K Datta4,5, Nandini A Sahasrabuddhe6, Aafaque Ahmad Khan7,8, Apeksha Sahu9,10, Anish Singhal11,12, Derese Getnet13, Rajesh Raju14,15, Aditi Chatterjee16,17, Harsha Gowda18,19, T S Keshava Prasad20,21, Subramanian Shankar22, Akhilesh Pandey23.   

Abstract

Interleukin-17 (IL-17) belongs to a relatively new family of cytokines that has garnered attention as the signature cytokine of Th17 cells. This cytokine family consists of 6 ligands, which bind to 5 receptor subtypes and induce downstream signaling. Although the receptors are ubiquitously expressed, cellular responses to ligands vary across tissues. The cytokine family is associated with various autoimmune disorders including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, asthma and psoriasis in addition to being implicated in the pathogenesis of cancer. In addition, this family plays a role in host defense against bacterial and fungal infections. The signaling mechanisms of the IL-17 family of proinflammatory cytokines are not well explored. In this study, we present a resource of literature-annotated reactions induced by IL-17. The reactions are catalogued under 5 categories, namely; molecular association, catalysis, transport, activation/inhibition and gene regulation. A total of 93 molecules and 122 reactions have been annotated. The IL-17 pathway is freely available through NetPath, a resource of signal transduction pathways previously developed by our group.

Entities:  

Keywords:  Activation; Differential expression; Inhibition; NetPath; Post-translational modifications; Protein-protein interaction; Translocation

Year:  2015        PMID: 26077014      PMCID: PMC4580681          DOI: 10.1007/s12079-015-0297-3

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  54 in total

1.  Cutting edge: interleukin 17 signals through a heteromeric receptor complex.

Authors:  Dean Toy; David Kugler; Martin Wolfson; Tim Vanden Bos; Jesse Gurgel; Jonathan Derry; Joel Tocker; Jacques Peschon
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E.

Authors:  Seon Hee Chang; Joseph M Reynolds; Bhanu P Pappu; Guangjie Chen; Gustavo J Martinez; Chen Dong
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

3.  IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1.

Authors:  J Lee; W H Ho; M Maruoka; R T Corpuz; D T Baldwin; J S Foster; A D Goddard; D G Yansura; R L Vandlen; W I Wood; A L Gurney
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

4.  IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.

Authors:  S G Hymowitz; E H Filvaroff; J P Yin; J Lee; L Cai; P Risser; M Maruoka; W Mao; J Foster; R F Kelley; G Pan; A L Gurney; A M de Vos; M A Starovasnik
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 5.  Innate IL-17-producing cells: the sentinels of the immune system.

Authors:  Daniel J Cua; Cristina M Tato
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

6.  Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells.

Authors:  Fei Huang; Cheng-Yuan Kao; Shinichiro Wachi; Philip Thai; Jisu Ryu; Reen Wu
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

7.  Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Authors:  Erik Lubberts; Marije I Koenders; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Christina J J Coenen-de Roo; Leo A B Joosten; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2004-02

8.  A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway.

Authors:  Rajesh Raju; Lavanya Balakrishnan; Vishalakshi Nanjappa; Mitali Bhattacharjee; Derese Getnet; Babylakshmi Muthusamy; Joji Kurian Thomas; Jyoti Sharma; B Abdul Rahiman; H C Harsha; Subramanian Shankar; T S Keshava Prasad; S Sujatha Mohan; Gary D Bader; Mohan R Wani; Akhilesh Pandey
Journal:  Database (Oxford)       Date:  2011-07-08       Impact factor: 3.451

9.  The BioPAX community standard for pathway data sharing.

Authors:  Emek Demir; Michael P Cary; Suzanne Paley; Ken Fukuda; Christian Lemer; Imre Vastrik; Guanming Wu; Peter D'Eustachio; Carl Schaefer; Joanne Luciano; Frank Schacherer; Irma Martinez-Flores; Zhenjun Hu; Veronica Jimenez-Jacinto; Geeta Joshi-Tope; Kumaran Kandasamy; Alejandra C Lopez-Fuentes; Huaiyu Mi; Elgar Pichler; Igor Rodchenkov; Andrea Splendiani; Sasha Tkachev; Jeremy Zucker; Gopal Gopinath; Harsha Rajasimha; Ranjani Ramakrishnan; Imran Shah; Mustafa Syed; Nadia Anwar; Ozgün Babur; Michael Blinov; Erik Brauner; Dan Corwin; Sylva Donaldson; Frank Gibbons; Robert Goldberg; Peter Hornbeck; Augustin Luna; Peter Murray-Rust; Eric Neumann; Oliver Ruebenacker; Oliver Reubenacker; Matthias Samwald; Martijn van Iersel; Sarala Wimalaratne; Keith Allen; Burk Braun; Michelle Whirl-Carrillo; Kei-Hoi Cheung; Kam Dahlquist; Andrew Finney; Marc Gillespie; Elizabeth Glass; Li Gong; Robin Haw; Michael Honig; Olivier Hubaut; David Kane; Shiva Krupa; Martina Kutmon; Julie Leonard; Debbie Marks; David Merberg; Victoria Petri; Alex Pico; Dean Ravenscroft; Liya Ren; Nigam Shah; Margot Sunshine; Rebecca Tang; Ryan Whaley; Stan Letovksy; Kenneth H Buetow; Andrey Rzhetsky; Vincent Schachter; Bruno S Sobral; Ugur Dogrusoz; Shannon McWeeney; Mirit Aladjem; Ewan Birney; Julio Collado-Vides; Susumu Goto; Michael Hucka; Nicolas Le Novère; Natalia Maltsev; Akhilesh Pandey; Paul Thomas; Edgar Wingender; Peter D Karp; Chris Sander; Gary D Bader
Journal:  Nat Biotechnol       Date:  2010-09-09       Impact factor: 54.908

Review 10.  The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.

Authors:  Sarah L Gaffen
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

View more
  13 in total

1.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

2.  An overview of the oxytocin-oxytocin receptor signaling network.

Authors:  Oishi Chatterjee; Krutika Patil; Apeksha Sahu; Lathika Gopalakrishnan; Praseeda Mol; Jayshree Advani; Srabani Mukherjee; Rita Christopher; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2016-09-14       Impact factor: 5.782

Review 3.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

4.  Topical heat shock protein 70 prevents imiquimod-induced psoriasis-like inflammation in mice.

Authors:  Federico G Seifarth; Julia E-M Lax; Jennifer Harvey; Paul E DiCorleto; M Elaine Husni; Unnikrishnan M Chandrasekharan; Michael Tytell
Journal:  Cell Stress Chaperones       Date:  2018-04-03       Impact factor: 3.667

5.  The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network.

Authors:  Apeksha Sahu; Lathika Gopalakrishnan; Nayana Gaur; Oishi Chatterjee; Praseeda Mol; Prashant Kumar Modi; Shobha Dagamajalu; Jayshree Advani; Sanjeev Jain; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2018-07-24       Impact factor: 5.782

Review 6.  A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis.

Authors:  Molly Campa; Bobbak Mansouri; Richard Warren; Alan Menter
Journal:  Dermatol Ther (Heidelb)       Date:  2015-12-29

7.  Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Expression In Vivo and In Vitro.

Authors:  Chun-Ming Shih; Chien-Yu Huang; Kuo-Hsien Wang; Chun-Yao Huang; Po-Li Wei; Yu-Jia Chang; Chi-Kun Hsieh; Kuan-Ting Liu; Ai-Wei Lee
Journal:  Int J Mol Sci       Date:  2018-09-03       Impact factor: 5.923

8.  Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A).

Authors:  K Callis Duffin; J Bagel; M Bukhalo; I J Mercado Clement; S L Choi; F Zhao; A Gill; B Pangallo; C Shuler; L Mallbris; K Jackson
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-08-08       Impact factor: 6.166

9.  IL-23R and IL-17A polymorphisms correlate with susceptibility of ankylosing spondylitis in a Southwest Chinese population.

Authors:  Bin Yang; Yuanwei Xu; Xinle Liu; Zhuochun Huang; Lanlan Wang
Journal:  Oncotarget       Date:  2017-08-18

Review 10.  IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.

Authors:  Nicoletta Bernardini; Nevena Skroza; Ersilia Tolino; Alessandra Mambrin; Alessia Anzalone; Veronica Balduzzi; Daniela Colapietra; Anna Marchesiello; Simone Michelini; Ilaria Proietti; Concetta Potenza
Journal:  Int J Dermatol       Date:  2019-10-30       Impact factor: 2.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.